- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03215134
Self-Criticism Feasibility Study
A Novel Intervention for Self-criticism in a Primary Care Psychological Therapies Service: Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The intervention is based upon recent unpublished doctoral research that developed this novel treatment within students with high levels of self-criticism. This pilot study aims to adapt the intervention for an Improving Access to Psychological Therapies (IAPT) service, a primary mental-health service in the UK.
Self-criticism is a transdiagnostic process across common mental-health disorders and is therefore, a potential target for psychological intervention. Clients at IAPT are likely to present with high levels of self-criticism. This pilot study may help develop an alternative evidence-based intervention that can be routinely offered within IAPT services.
The researchers aim to recruit 20 clients registered at Talking Therapies Southwark, experiencing a significant impact of self-criticism on their daily life, and requesting help for self-criticism. Clients that provide consent to participate in this study would receive 6 sessions of this intervention and a 2-month follow-up telephone session.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE5 8AF
- South London and Maudsley NHS Foundation Trust (SlaM) and Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London (KCL)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Written informed consent
- Registered with and opt into the Southwark IAPT service, Talking Therapies Southwark
- Score at least 10 on the WSAS questionnaire regarding the impact of self-criticism on their daily life
- Requesting help for their self-criticism.
Exclusion Criteria:
- Not being sufficiently proficient in English to fully participate in the sessions with English-speaking therapists or process the written study materials for any reason.
- Being unable to attend six sessions of assessment/treatment.
- Presenting with high levels of risk requiring monitoring and assistance beyond the weekly intervention focusing on self-criticism.
- Current serious mental health problem such as bipolar disorder, anorexia nervosa or a moderate / severe substance use disorder.
- Cognitive impairment or psychomotor retardation of a degree that would prevent completion of the study treatment protocol with the individual. This would be based on a clinical judgement by potential referrers or by the clinician undertaking the screening assessment.
- Currently experiencing a degree of life stress (e.g. recent bereavement) that is judged by the assessor to be likely to seriously adversely affect their ability to benefit from the intervention
- New pharmacological interventions for psychological distress - i.e. a change of medication or dosage in the last 4 weeks.
- Current participation in another clinical (talking therapy or drug) trial or another psychological intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Self-criticism intervention
6 weekly face to face therapy sessions (1st assessment an intervention session of 60 to 90 minutes; sessions 2-5 are 60 minutes each) and a 2 month follow-up telephone call of upto 30 minutes.
|
Compassion Focused Therapy (Gilbert, 2010) adapted to focus specifically on reducing self-criticism.
This intervention was originally developed for a student population (Rose, McIntyre & Rimes, submitted) and is now being evaluated in a primary mental-health service.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Do clients find the intervention an acceptable treatment option
Time Frame: 3.5 months (from start to end of therapy, including follow-up)
|
This will be assessed through anonymised written feedback
|
3.5 months (from start to end of therapy, including follow-up)
|
|
Is this intervention feasible to deliver within an IAPT service
Time Frame: 9 months - through recruitment until the end of therapy for the final participant.
|
This will be assessed through recruitment and retention rates
|
9 months - through recruitment until the end of therapy for the final participant.
|
|
Work and Social Adjustment Scale (W&SAS) adapted to reflect self-criticism
Time Frame: Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
Measure of the impact of the presenting problem, in this case, self-criticism.
Change is being assessed.
|
Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
|
Self-Critical Rumination Scale (SCRS)
Time Frame: Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
Measure of self-criticism.
Change is being assessed.
|
Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
Depressive symptoms scale.
Change is being assessed.
|
Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
|
Generalised Anxiety Disorder scale (GAD-7)
Time Frame: Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
Anxiety related symptoms scale.
Change is being assessed.
|
Change from baseline will be measured again at each time-point: session 1,2,3,4,5, 6; and 2 months after session 6.
|
|
Rosenberg Self-Esteem Scale
Time Frame: Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
Measure of self-esteem.
Change is being assessed.
|
Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
|
Habitual Index of Negative Thinking
Time Frame: Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
Measure of negative self-thinking.
Change is being assessed.
|
Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
|
Forms of Self-Criticising/Attacking and Self-Reassuring Scale
Time Frame: Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
measure of criticism.
Change is being assessed.
|
Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Compassion Scale
Time Frame: Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
Process measure reflecting levels of self-compassion.
Change is being assessed.
|
Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
|
Beliefs about Emotion Scale
Time Frame: Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
Process measure reflecting the acceptability of negative emotions.
Change is being assessed.
|
Change from baseline will be measured again at session 1,4,6, and 2 months after session 6.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mehul Elliott-Joshi, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), Kings College London; South London and Maudsley (SLaM) NHS Foundation Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17/LO/0335
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Self-Criticism
-
University of WaterlooCompleted
-
University of BernCompletedSelf-criticismSwitzerland
-
University Medical Center GroningenUniversity of Groningen; PPOCompletedSelf-CriticismNetherlands
-
York UniversityFederal Economic Development Agency for Southern OntarioCompleted
-
Brigham Young UniversityTerminatedCompassion | Guilt | Self-Criticism | ShameUnited States
-
University Hospital HeidelbergCompletedPsychological Distress | Self-Criticism | In-Patient Treatment
-
University of SheffieldActive, not recruitingDepression | Wellbeing | Stress | Anxiety | ADHD | Self-Criticism | Self-compassionUnited Kingdom
-
Region ÖstergötlandCompletedAnxiety | Depressive Symptoms | Nonsuicidal Self Injury | Adolescent - Emotional Problem | Adolescent Problem Behavior | Self-CriticismSweden
-
Uppsala UniversityÖrebro University, Sweden; Uppsala University Hospital; Karlstad UniversityCompletedChronic Pain | Self-CriticismSweden
-
Teachers College, Columbia UniversityRecruitingDepression | Anxiety | Distress, Emotional | Rumination | Self-Criticism | WorryUnited States
Clinical Trials on Self-criticism intervention
-
Region ÖstergötlandCompletedAnxiety | Depressive Symptoms | Nonsuicidal Self Injury | Adolescent - Emotional Problem | Adolescent Problem Behavior | Self-CriticismSweden
-
University Medical Center GroningenUniversity of Groningen; PPOCompletedSelf-CriticismNetherlands
-
The University of Hong KongTung Wah Group of HospitalsCompletedParenting | Family | Family Research
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedMultiple Sclerosis | Low Back Pain | Chronic Pain | Muscular Dystrophies | Spinal Cord Injury | Other and Unspecified Amputation Stump ComplicationsUnited States
-
Wake Forest University Health SciencesAlzheimer's AssociationCompletedAlzheimer DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHealthy SubjectUnited States
-
Nigde Omer Halisdemir UniversityRecruitingSleep Disturbance | Sleep Quality | Social Jet Lag | Circadian Rhythm DisruptionTurkey (Türkiye)
-
Columbia UniversityWithdrawn
-
University of ÉvoraRecruiting
-
Instituto de Cardiologia do Rio Grande do SulUniversidade de Caxias do SulCompleted